A recent survey from the North American Neuro-Ophthalmology Society (NANOS) recently demonstrated that the median wait time to receive care for new patients, many of whom present with acute concern, is 6 weeks [1]
What is the recommended starting dose and titration for GLP-1 (Glucagon-Like Peptide-1) Receptor Agonist (RA) therapy, such as liraglutide (Victoza) or semaglutide (Ozempic), in patients with type 2 diabetes?
Not only do patients experience better management of their diabetes, but they also see significant reductions in body weight, which contributes to an overall improvement in their health and quality of life
Investigators continue to study BPC-157 for its influence on cellular communication, angiogenic signaling, tissue remodeling, and the complex biological processes involved in maintaining tissue homeostasis following physiological stress
Benefits Beyond the Scale For many people, weight loss is only part of the story